Thank you for Subscribing to Life Science Review Weekly Brief
×
Life Science Review Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review
How Integrating IIoT with LIMS Can Enhance Lab...
Aviana Rios, Director, Digital Technology, Viatris
Re-imagining Learning in a Post-Pandemic World
Sebastian Teo, Head of Learning & Talent Management, Linde
Specialized Services: A New Paradigm in...
Brian D. Fry, Senior Director, Cell Therapy CDMO, Charles River Laboratories
Antibodies: The Building Blocks of Cures
John Armstrong, Head of Research; Head of BD; Global Strategic Programs; Global Straegic Marketing, Galderma
Raising capital for early stage biotech start-ups
Dr. John Kurek, Inverstment Manager and Dr. Peter Devine, CEO, Uniseed
How Will Digital Transformation Revolutionize...
Robert Peterson, Head Of Sales Health and Life Sciences Americas and Asia, BT - Health and Life Sciences
Managing Impacts of Technology Transformations...
Olga Minkov, Executive Director, Operations - Pharmacovigilance & Epi, Gilead Sciences
How a Clinical Focus Group and Electronic...
Michael Marino, SVP & Chief Medical Information Officer, Providence St. Joseph Health
Challenges and Opportunities for AI in Drug...
Robert J Prill, Director, Data Science and AI, Computational Biology and Data Sciences, and
How Integrating IIoT with LIMS Can Enhance Lab Operations
Aviana Rios, Director, Digital Technology, Viatris
Re-imagining Learning in a Post-Pandemic World
Sebastian Teo, Head of Learning & Talent Management, Linde
Specialized Services: A New Paradigm in Therapeutics
Brian D. Fry, Senior Director, Cell Therapy CDMO, Charles River Laboratories
Antibodies: The Building Blocks of Cures
John Armstrong, Head of Research; Head of BD; Global Strategic Programs; Global Straegic Marketing, Galderma
Raising capital for early stage biotech start-ups
Dr. John Kurek, Inverstment Manager and Dr. Peter Devine, CEO, Uniseed
How Will Digital Transformation Revolutionize The Pharma Sector In The Light Of The Covid-19 Pandemic?
Robert Peterson, Head Of Sales Health and Life Sciences Americas and Asia, BT - Health and Life Sciences
Managing Impacts of Technology Transformations in Pharmacovigilance
Olga Minkov, Executive Director, Operations - Pharmacovigilance & Epi, Gilead Sciences
How a Clinical Focus Group and Electronic Medical Records Improved Post-Partum Outcomes
Michael Marino, SVP & Chief Medical Information Officer, Providence St. Joseph Health
Challenges and Opportunities for AI in Drug Discovery
Robert J Prill, Director, Data Science and AI, Computational Biology and Data Sciences, and
Machine Learning in the Life Sciences
Eric Staib, Vice President, Compliance & Quality Management, Signant Health
Covid-19 as a Catalyst for Digital Transformation of Clinical Research: Are We There Yet?
Dr. Ammar Raza, Regional Medical Director- Middle East and Africa, Allergan Aesthetics, an AbbVie company, Dubai
De-risking the Preclinical Phase of Immunotherapy Drug Development
Ralph Gareus, Director Business Development, The Jackson Laboratory
How we're Leveraging New Technological Advancements by Building a Cell & Gene Therapy Business unit within an Established Pharmaceutical Company
Medical Affairs Takes Centre Stage
Featured Vendor
How Can Artificial Intelligence Improve Clinical Trials?
Jorine Putter, Head of Advanced Analytics at Grünenthal and Yuri Martina, Head of Development at Grünenthal
Immunotherapy in Lung Cancer: building towards a patient-tailored future
James Holland, PhD. Senior Medical Writer, Ashfield Health
New Impella 5.5 Heart Pump Device Provides Potentially Life-Saving Treatment Option for Patients with Cardiogenic Shock
Mark Anderson, M.D., Chief of the Division of Cardiac Surgery and Cardiothoracic Surgeon at the Heart and Vascular Hospital at Hackensack University Medical Center and Hackensack Meridian Health.
Like a Tailored Suit: Producing Customized Viral Vectors that Respond to Market Demands
Margherita Neri, Vector Process Development Manager, and Giuliana Vallanti, Director, Development and Global R&D Cell and Gene, Anna Stornaiuolo, AGC Biologics
